1. Home
  2. EHTH vs KPTI Comparison

EHTH vs KPTI Comparison

Compare EHTH & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

N/A

Current Price

$1.20

Market Cap

46.0M

Sector

Finance

ML Signal

N/A

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

N/A

Current Price

$1.87

Market Cap

47.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EHTH
KPTI
Founded
1997
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.0M
47.6M
IPO Year
2006
2013

Fundamental Metrics

Financial Performance
Metric
EHTH
KPTI
Price
$1.20
$1.87
Analyst Decision
Hold
Strong Buy
Analyst Count
3
7
Target Price
$3.33
$16.00
AVG Volume (30 Days)
228.5K
2.4M
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
N/A
EPS
N/A
N/A
Revenue
$251,395,000.00
$146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
45.86
0.57
52 Week Low
$1.14
$1.79
52 Week High
$5.89
$10.99

Technical Indicators

Market Signals
Indicator
EHTH
KPTI
Relative Strength Index (RSI) 37.55 25.05
Support Level N/A $1.79
Resistance Level $1.58 $2.18
Average True Range (ATR) 0.05 0.14
MACD 0.00 0.25
Stochastic Oscillator 21.43 41.03

Price Performance

Historical Comparison
EHTH
KPTI

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: